Nov 28 |
INVO Bioscience Regains Compliance with Nasdaq Minimum Stockholders' Equity Requirement
|
Nov 14 |
INVO BioScience GAAP EPS of -$0.70 beats by $0.17, revenue of $0.97M misses by $0.96M
|
Nov 13 |
INVO Reports Record Third Quarter 2023 Financial Results
|
Nov 13 |
BestGrowthStocks.Com Issues Comprehensive Analysis Regarding INVO Biosciences Merger
|
Nov 10 |
Dow Gains Over 100 Points; Wynn Resorts Earnings Top Views
|
Nov 10 |
NAYA Biosciences and INVO Bioscience Announce Appointment of Dr. Peter Kash, Ed.D., MBA as Vice Chairman Following Closing of Their Pending Merger
|
Nov 9 |
INVO Bioscience Announces Commencement of Waiver Solicitation From Holders of the Company's Common Stock Purchase Warrants
|